<VariationArchive VariationID="956975" VariationName="NM_003042.4(SLC6A1):c.25del (p.Ala9fs)" VariationType="Deletion" Accession="VCV000956975" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="943250" VariationID="956975">
      <GeneList>
        <Gene Symbol="SLC6A1-AS1" FullName="SLC6A1 antisense RNA 1" GeneID="100874090" HGNC_ID="HGNC:40546" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="11006098" stop="11019224" display_start="11006098" display_stop="11019224" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="SLC6A1" FullName="solute carrier family 6 member 1" GeneID="6529" HGNC_ID="HGNC:11042" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10992748" stop="11039247" display_start="10992748" display_stop="11039247" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11034419" stop="11080934" display_start="11034419" display_stop="11080934" Strand="+" />
          </Location>
          <OMIM>137165</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003042.4(SLC6A1):c.25del (p.Ala9fs)</Name>
      <CanonicalSPDI>NC_000003.12:11017234:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="11017235" stop="11017235" display_start="11017235" display_stop="11017235" variantLength="1" positionVCF="11017234" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11058921" stop="11058921" display_start="11058921" display_stop="11058921" variantLength="1" positionVCF="11058920" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A9fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.11058922del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.11058922del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.11017236del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.11017236del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053003.1" sequenceAccession="NG_053003" sequenceVersion="1" change="g.29508del">
            <Expression>NG_053003.1:g.29508del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348250.2" sequenceAccession="NM_001348250" sequenceVersion="2" change="c.25del">
            <Expression>NM_001348250.2:c.25del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335179.1" sequenceAccession="NP_001335179" sequenceVersion="1" change="p.Ala9fs">
            <Expression>NP_001335179.1:p.Ala9fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348251.2" sequenceAccession="NM_001348251" sequenceVersion="2" change="c.-146del">
            <Expression>NM_001348251.2:c.-146del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348252.2" sequenceAccession="NM_001348252" sequenceVersion="2" change="c.-188del">
            <Expression>NM_001348252.2:c.-188del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348253.2" sequenceAccession="NM_001348253" sequenceVersion="2" change="c.-188del">
            <Expression>NM_001348253.2:c.-188del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003042.4" sequenceAccession="NM_003042" sequenceVersion="4" change="c.25del" MANESelect="true">
            <Expression>NM_003042.4:c.25del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003033.3" sequenceAccession="NP_003033" sequenceVersion="3" change="p.Ala9fs">
            <Expression>NP_003033.3:p.Ala9fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1697186082" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.25del (p.Ala9fs) AND Myoclonic-astatic epilepsy" Accession="RCV003444801" Version="1">
        <ClassifiedConditionList TraitSetID="72209">
          <ClassifiedCondition DB="MedGen" ID="C0393702">Myoclonic-astatic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25865495</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="72209" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="29076" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Generalized myoclonic-atonic seizure</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic atonic seizures</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myoclonic-astatic epilepsy</ElementValue>
                <XRef ID="MONDO:0016025" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2169" />
                <XRef ID="2169" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="C0393702" DB="MedGen" />
              <XRef ID="MONDO:0016025" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011170" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2737337" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6777494|MedGen:C4085238" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001402338" DateUpdated="2022-05-16" DateCreated="2020-07-16" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25865495</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala9Profs*75) in the SLC6A1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SLC6A1-related conditions. Loss-of-function variants in SLC6A1 are known to be pathogenic (PMID: 25865495). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.11058921del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4085238" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2737337" TraitType="Disease" MappingType="XRef" MappingValue="C4085238" MappingRef="MedGen">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

